NCT00079092 2021-09-09
Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma
Wake Forest University Health Sciences
Phase 2 Completed
Wake Forest University Health Sciences
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center